↓ Skip to main content

Cyclin D1, EMS1 and 11q13 Amplification in Breast Cancer

Overview of attention for article published in Breast Cancer Research and Treatment, April 2003
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent
2 patents

Citations

dimensions_citation
228 Dimensions

Readers on

mendeley
69 Mendeley
Title
Cyclin D1, EMS1 and 11q13 Amplification in Breast Cancer
Published in
Breast Cancer Research and Treatment, April 2003
DOI 10.1023/a:1023033708204
Pubmed ID
Authors

Christopher J. Ormandy, Elizabeth A. Musgrove, Rina Hui, Roger J. Daly, Robert L. Sutherland

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 1%
Argentina 1 1%
Unknown 67 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 23%
Student > Ph. D. Student 13 19%
Student > Master 7 10%
Student > Postgraduate 6 9%
Other 5 7%
Other 7 10%
Unknown 15 22%
Readers by discipline Count As %
Medicine and Dentistry 19 28%
Agricultural and Biological Sciences 15 22%
Biochemistry, Genetics and Molecular Biology 10 14%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Mathematics 1 1%
Other 4 6%
Unknown 16 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 November 2016.
All research outputs
#5,611,796
of 26,017,215 outputs
Outputs from Breast Cancer Research and Treatment
#1,060
of 5,117 outputs
Outputs of similar age
#10,741
of 65,122 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#5
of 30 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,117 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 65,122 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.